Top Markets
#1 Nesa Nesa +812.17%
#2 Cortex Cortex +68.84%
#3 Merlin's Seal BTC Merlin's Seal BTC +45.80%
#4 EXOD EXOD +22.78%
#5 QuantixAI QuantixAI +11.68%
#6 Fartcoin Fartcoin +10.33%
#7 Venom Venom +10.18%
#8 Pons Pons +10.06%
#9 PondCoin PondCoin +8.91%
#10 Movement Movement +8.72%
Coin of the day
Nesa Nesa
Settings
Language
ENGLISH
Currency
USD
Theme
Definium Therapeutics, Inc. Definium Therapeutics, Inc.

Definium Therapeutics, Inc.

DFTX
Rank in Stocks #3208
Definium Therapeutics, Inc. operates as a clinical-stage biopharmaceutical firm... Definium Therapeutics, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to developing innovative therapeutic solutions for various brain health and neurological disorders. Its pipeline features key experimental drug candidates like MM120, which is currently undergoing Phase 3 clinical trials for generalized anxiety disorder (GAD) and attention deficit hyperactivity disorder (ADHD). Another significant compound, MM402 – an R-enantiomer of 3,4-methylenedioxymethamphetamine – is in Phase 1 trials, targeting the fundamental symptoms of autism spectrum disorder. The company maintains its headquarters in New York, New York.
Share Price
$44.42
Last synced: 2026-08-25
Market Cap
$5.90B
Change (1 day)
2.66%
Change (1 year)
344.66%
Country
US
Trade Definium Therapeutics, Inc. (DFTX)

Category

Healthcare
Earnings for Definium Therapeutics, Inc. (DFTX)
Earnings in 2026 TTM: 0
According to Definium Therapeutics, Inc. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Definium Therapeutics, Inc. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH